Yes, Lupron Treats Uterine Fibroids
Lupron (leuprolide acetate) is an FDA-approved GnRH agonist that shrinks uterine fibroids by suppressing estrogen production, which fuels fibroid growth. Doctors use it short-term—typically 3-6 months—to reduce fibroid size and heavy bleeding before surgery or as a bridge to menopause.[1]
How Lupron Works for Fibroids
It mimics gonadotropin-releasing hormone, initially causing a temporary estrogen surge (flare effect) before drastically lowering levels. This creates a pseudomenopause state, cutting fibroid volume by 30-60% on average. Effects reverse after stopping, so it's not a permanent fix.[1][2]
Common Usage and Dosage
Prescribed as monthly or 3-month depot injections (3.75 mg or 11.25 mg). Often combined with low-dose estrogen/progestin "add-back" therapy to ease side effects like hot flashes and bone loss. Not for long-term use due to risks.[2]
What Happens After Treatment?
Fibroids regrow in most cases within 6-12 months without follow-up interventions like hysterectomy, myomectomy, or embolization. It's most effective for women nearing menopause or pre-surgery.[1]
Side Effects Patients Report
Hot flashes (80%+ of users), headaches, mood changes, vaginal dryness, and decreased libido. Rare risks include osteoporosis with prolonged use and cardiovascular issues. Add-back therapy mitigates many.[2]
Alternatives to Lupron
- Tranexamic acid or NSAIDs: For bleeding control without hormonal changes.
- Oral GnRH antagonists (e.g., relugolix in Myfembree): Daily pills with fewer injections and built-in add-back.
- Uterine artery embolization: Non-hormonal procedure.
- Focused ultrasound: Noninvasive option for select fibroids.[1][3]
Who Should Avoid It?
Not for pregnant women, those with osteoporosis history, or breastfeeding. Monitor bone density during/after use.[2]
[1]: FDA Label for Lupron Depot
[2]: ACOG Guidelines on Fibroids
[3]: DrugPatentWatch.com - Lupron Patents